Related Experiment Video
Updated: Apr 1, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Calciphylaxis in Patients With Preserved Kidney Function
Natallia Maroz1, Samer Mohandes2, Halle Field3
1Renal Physicians Inc., Dayton, OH, USA ; Department of Medicine, Wright State University, Boonshoft School of Medicine, Dayton, OH, USA.
Insights
Calcific uremic arteriolopathy (CUA), or calciphylaxis, causes painful wounds in dialysis patients. This study explores non-uremic calciphylaxis (NUC) management and outcomes in patients without kidney disease.
Area of Science:
- Nephrology
- Dermatology
- Vascular Medicine
Background:
- Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a severe condition affecting end-stage renal disease patients.
- CUA presents as painful, symmetrical wounds that are challenging to treat.
- Non-uremic calciphylaxis (NUC) occurs in patients without kidney disease, but its management and outcomes are poorly understood.
Purpose of the Study:
- To describe clinical scenarios of non-uremic calciphylaxis (NUC).
- To report on therapeutic interventions for wound management in NUC.
- To contribute to the evidence base for effective NUC treatment strategies.
Main Methods:
- Case series describing three patients diagnosed with NUC.
- Detailed reporting of wound management interventions.
- Documentation of both successful and unsuccessful therapeutic outcomes.
Main Results:
- Three distinct clinical cases of NUC were presented.
- Various wound management strategies were applied.
- The effectiveness and limitations of different interventions were observed.
Conclusions:
- NUC can occur in patients without significant kidney pathology.
- Documenting therapeutic interventions in NUC is crucial.
- Further research is needed to establish optimal NUC management protocols.
Abstract:
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a devastating disease typically seen in patients with end stage renal disease. It manifests as extremely painful symmetrical wounds resistant to surgical and medical interventions. The prevalence of CUA among hemodialysis dependent patients was found to be as high as 4.1%. The management of patients with CUA requires a multidisciplinary approach by the medical team, yet often results in a low rate of successful outcomes. Recently, non-uremic calciphylaxis (NUC) has been described in the absence of kidney disease. Limited knowledge exists on the management of NUC and the outcomes of this condition. Herein we describe three clinical scenarios of patients diagnosed with NUC in the absence of permanent or prolonged acute renal pathology. The reporting of successful and fruitless therapeutic interventions for wound management in NUC is important for compiling the evidence of effective therapeutic strategies.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Acute Kidney Injury V: Interprofessional Care

